Pathogenesis of metabolic dysfunction-associated steatotic liver disease and donor liver damage
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects more than a quarter of adults worldwide. MASLD is associated with severe medical burdens and leads to further reduction of the donor pool for liver transplantation. However, there is a lack of systematic evaluation of the patho...
| Published in: | iLIVER |
|---|---|
| Main Authors: | Chuheng Gou, Wenjie Zhang, Hao Xu, Hong Zhang, Rui Ding, Xuan Zhang |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-12-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772947825000532 |
Similar Items
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease
by: Tiansu Lv, et al.
Published: (2024-02-01)
by: Tiansu Lv, et al.
Published: (2024-02-01)
Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics
by: Gary Huang, et al.
Published: (2023-10-01)
by: Gary Huang, et al.
Published: (2023-10-01)
A new name for an old problem. Metabolic dysfunction-associated steatotic liver disease - review of literature
by: Adrian Kruszewski, et al.
Published: (2024-07-01)
by: Adrian Kruszewski, et al.
Published: (2024-07-01)
Applicability of Statins in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
by: Thaninee Prasoppokakorn
Published: (2025-01-01)
by: Thaninee Prasoppokakorn
Published: (2025-01-01)
The Role of Neuregulin-1 in Steatotic and Non-Steatotic Liver Transplantation from Brain-Dead Donors
by: Marc Micó-Carnero, et al.
Published: (2022-04-01)
by: Marc Micó-Carnero, et al.
Published: (2022-04-01)
Validation of the American Association for the Study of Liver Disease/European Association for the Study of the Liver Multistep Screening Strategies for Metabolic Dysfunction-associated Steatotic Liver disease
by: Clémence Marie Canivet, et al.
Published: (2025-01-01)
by: Clémence Marie Canivet, et al.
Published: (2025-01-01)
METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: UPDATE
by: Maria Gabriela Fernandes DEZAN, et al.
Published: (2025-09-01)
by: Maria Gabriela Fernandes DEZAN, et al.
Published: (2025-09-01)
Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
by: Katharina Staufer, et al.
Published: (2023-07-01)
by: Katharina Staufer, et al.
Published: (2023-07-01)
Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease
by: Georg Semmler, et al.
Published: (2023-09-01)
by: Georg Semmler, et al.
Published: (2023-09-01)
Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality
by: Donghee Kim, et al.
Published: (2024-10-01)
by: Donghee Kim, et al.
Published: (2024-10-01)
A Multidrug Donor Preconditioning Improves Steatotic Rat Liver Allograft Function and Recipient Survival After Transplantation
by: Min Xu, et al.
Published: (2024-12-01)
by: Min Xu, et al.
Published: (2024-12-01)
Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer
by: Samuel O. Antwi, et al.
Published: (2025-01-01)
by: Samuel O. Antwi, et al.
Published: (2025-01-01)
Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
by: Jacob Romano, et al.
Published: (2025-01-01)
by: Jacob Romano, et al.
Published: (2025-01-01)
Steatotic liver disease in people with HIV at Tshepong Hospital: A post-mortem analysis
by: Aqeela Moosa, et al.
Published: (2024-12-01)
by: Aqeela Moosa, et al.
Published: (2024-12-01)
Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
by: Jiaxin Chen, et al.
Published: (2024-06-01)
by: Jiaxin Chen, et al.
Published: (2024-06-01)
An overview of pathogenesis of metabolic dysfunction-associated steatotic liver disease
by: Shahid Habib, et al.
Published: (2024-11-01)
by: Shahid Habib, et al.
Published: (2024-11-01)
Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
by: Yuri Cho
Published: (2024-11-01)
by: Yuri Cho
Published: (2024-11-01)
Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases
by: Madan Kumar Arumugam, et al.
Published: (2023-10-01)
by: Madan Kumar Arumugam, et al.
Published: (2023-10-01)
Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)
Treatment of HCV infection in patients with steatotic liver disease
by: Robert Flisiak, et al.
Published: (2024-07-01)
by: Robert Flisiak, et al.
Published: (2024-07-01)
ASSOCIATION BETWEEN ANXIETY AND DEPRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
by: Eloyse Cristina BOTACIN, et al.
Published: (2024-07-01)
by: Eloyse Cristina BOTACIN, et al.
Published: (2024-07-01)
Effect of a Ketogenic Diet on Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial
by: Sakkarin Chirapongsathorn, et al.
Published: (2025-01-01)
by: Sakkarin Chirapongsathorn, et al.
Published: (2025-01-01)
Hyperferritinemia and the Risk of Liver Fibrosis and Liver-Related Events in Patients with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Simona Cernea, et al.
Published: (2025-08-01)
by: Simona Cernea, et al.
Published: (2025-08-01)
Lipidome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys with Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Helaina E. Huneault, et al.
Published: (2024-03-01)
by: Helaina E. Huneault, et al.
Published: (2024-03-01)
Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study
by: Michihiro Iwaki, et al.
Published: (2024-04-01)
by: Michihiro Iwaki, et al.
Published: (2024-04-01)
Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01)
by: K. L. Raikhelson, et al.
Published: (2024-05-01)
Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis
by: Farah Abdelhameed, et al.
Published: (2025-04-01)
by: Farah Abdelhameed, et al.
Published: (2025-04-01)
A high reticulocyte count is a risk factor for the onset of metabolic dysfunction-associated steatotic liver disease: Cross-sectional and prospective studies of data of 310,091 individuals from the UK Biobank
by: Peng-Cheng Ma, et al.
Published: (2024-07-01)
by: Peng-Cheng Ma, et al.
Published: (2024-07-01)
Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway
by: Shenghe Deng, et al.
Published: (2025-12-01)
by: Shenghe Deng, et al.
Published: (2025-12-01)
Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on “Epidemiology of metabolic dysfunction-associated steatotic liver disease”
by: Lin Guan, et al.
Published: (2025-04-01)
by: Lin Guan, et al.
Published: (2025-04-01)
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
by: Bruno Basil, et al.
Published: (2024-12-01)
by: Bruno Basil, et al.
Published: (2024-12-01)
Impact of cholecystectomy on Metabolic dysfunction-Associated Steatotic Liver Disease and metabolic syndrome: a 6-month prospective cohort study
by: Mohammad Hadi Bahri, et al.
Published: (2025-09-01)
by: Mohammad Hadi Bahri, et al.
Published: (2025-09-01)
A new Korean nomenclature for steatotic liver disease
by: Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
Published: (2024-09-01)
by: Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
Published: (2024-09-01)
Sex-specific associations of metabolic dysfunction-associated steatotic liver disease with cardiovascular outcomes
by: Meng-Yuan Miao, et al.
Published: (2025-01-01)
by: Meng-Yuan Miao, et al.
Published: (2025-01-01)
Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver diseaseKey points
by: Guillaume Henin, et al.
Published: (2024-02-01)
by: Guillaume Henin, et al.
Published: (2024-02-01)
New steatotic liver disease criteria diagnostic performance in an agricultural population in Chile
by: Maria Spencer-Sandino, et al.
Published: (2025-07-01)
by: Maria Spencer-Sandino, et al.
Published: (2025-07-01)
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
by: Gi-Ae Kim, et al.
Published: (2023-10-01)
by: Gi-Ae Kim, et al.
Published: (2023-10-01)
Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
by: Byeong Geun Song, et al.
Published: (2024-03-01)
by: Byeong Geun Song, et al.
Published: (2024-03-01)
A social media listening study of patients’ experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD study
by: Jeffrey V. Lazarus, et al.
Published: (2025-01-01)
by: Jeffrey V. Lazarus, et al.
Published: (2025-01-01)
Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs
by: Baoqiang Zhu, et al.
Published: (2023-11-01)
by: Baoqiang Zhu, et al.
Published: (2023-11-01)
Similar Items
-
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease
by: Tiansu Lv, et al.
Published: (2024-02-01) -
Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics
by: Gary Huang, et al.
Published: (2023-10-01) -
A new name for an old problem. Metabolic dysfunction-associated steatotic liver disease - review of literature
by: Adrian Kruszewski, et al.
Published: (2024-07-01) -
Applicability of Statins in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
by: Thaninee Prasoppokakorn
Published: (2025-01-01) -
The Role of Neuregulin-1 in Steatotic and Non-Steatotic Liver Transplantation from Brain-Dead Donors
by: Marc Micó-Carnero, et al.
Published: (2022-04-01)
